William Cameron Scott Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 208 Sunflower Ave, Clarksdale, MS 38614 Phone: 662-890-0012 |
Dr. Patricia A Johnson, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 323 Delta Ave, Clarksdale, MS 38614 Phone: 662-627-7640 |
Mid South Chiropractic Of Clarksdale Pllc Chiropractor Medicare: Medicare Enrolled Practice Location: 218 Delta Ave, Clarksdale, MS 38614 Phone: 662-627-7640 Fax: 662-890-0522 |
Dr. Alia Marguerite Mccoy, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 323 Delta Ave, Clarksdale, MS 38614 Phone: 662-627-7640 Fax: 662-627-7640 |
News Archive
REACH3 - healthcare CRM's market leader, enabling robust provider and payer marketing initiatives through secure, cloud-based technology - announced today that HealthAlliance of the Hudson Valley has chosen to implement its CRM Custom solution to strengthen its consumer and patient marketing campaigns, as well as enhance the unified brand identity of its newly formed health system.
The Premier healthcare alliance has contracted with AirStrip Technologies™, L.P. to offer its 2,200 hospitals members a mobile healthcare information technology (HIT) solution to improve obstetrical (OB) care, patient safety and communication among healthcare providers.
Delivering news about end-of-life issues is one of the most difficult tasks clinicians encounter in medical practice. Researchers from the Texas Medical Center on behalf of the ETHICS study investigators, in Houston, Texas, aimed to assess how prepared health-care providers feel in communicating end-of-life issues and determining if proper training had been given to health-care providers.
Preterm birth - defined as birth before the 37th week of gestation - is the leading complication of pregnancy. If doctors had a simple, accurate and inexpensive way to identify women at risk for the condition, they could develop better prevention strategies.
StemCells, Inc. announced today that it has submitted a protocol to the FDA for initiation of a second clinical trial of its proprietary HuCNS-SC human neural stem cells in neuronal ceroid lipofuscinosis, which is also often referred to as Batten disease.
› Verified 9 days ago